...
ClinSpark is the only CDISC ODM certified eSource and automation platform for early phase clinical trials and site automation for all phases. We use AWS' class-leading hosting services in either North American or EU (and coming soon in future AsianAPAC) regions.
We supply ClinSpark to a number of CROs and Pharmaceutical Company Phase I units in the US and Europe and are engaging with our first sites in APAC.
ClinSpark is different to EDC systems, where the source data is captured on paper and then transcribed to an eCRF. EDC is usually deployed by the sponsor or CRO and used on demand, one study at a time. However, with eSource, it is the sites themselves that adopt ClinSpark as their platform for the conduct of all their clinical trials, and as a way to increase compliance, reduce errors and increase efficiency, as well as delivering SDTM-like exports in SAS® transport file format. In addition, the sites provide controlled and secure access to the source data in ClinSpark, to the trial sponsor and/or trial monitors. Importantly, the data is owned and retained by the investigational site.
...
We currently support a range of VS, ECG and other medical device and instruments integrations from several vendors including HillRom, Baxter (Mortara), WelchAllyn, GE Medical, seca and Konica Minolta. These integrations eliminate demographic and transcription errors and store the captured source data directly in the database including ECG XML and PDFs of waveforms. ClinSpark includes an optional integration with CalECG by AMPS LLC that allows on-screen measurement of ECG signals that would normally be the domain of cardiac core labs. We have recently added integrations with additional devices including for the measurement of spirometry and blood glucose initially for later phase trials.
...
Our customers found that using ClinSpark for the conduct of clinical trials during the COVID19 public health emergency to be of great value, as many sponsor oversight and monitoring tasks could be conducted remotely.
In conclusion, ClinSpark is very much a strategic investment for a site or early phase CRO, in order to adopt eSource as an operating platform for all their trials, and is not necessarily intended as a tactical solution to be used for individual trials.
...
Data vs Paper
All Phase I clinics and later phase research teams face similar challenges: Lots of data, systems, assessments, changes, paper and spreadsheets. So how to keep focused on volunteer safety and study results?
...
Learn in one minute what ClinSpark is and how it can help solve your clinical research challenges.
...
Connect, Collaborate, Accelerate
...
See how ClinSpark connects to your ECG-device or telemetry system and collects data automatically. Learn how to review and analyse ECGs using class leading software as used by most ECG Core-labs, straight from within ClinSpark.
...
Software as a Service
ClinSpark is fully cloud-based and is offered exclusively as a SaaS solution with a subscription-based pricing model.
This has some great advantages for you:
...
We are so convinced about our offering that we provide ClinSpark without a long-term contract. You can cancel anytime with a month's notice.
Foundry Health, an IQVIA business
Foundry Health, an IQVIA business, is a digital health company that seeks to empower health professionals by building software tools that put the patient back at the center of each encounter.
We believe in challenging the status quo by creating strategic solutions that reflect researcher needs, industry trends and “out of the box” thinking. We do this to increase subject empathy and compassion while speeding up the delivery of tomorrow’s drugs for today’s illnesses.
...
Who We Are
We are a team of enthusiastic professionals with the sole focus to make ClinSpark the new standard for eSource platforms in clinical research.
We are proud to have a very enthusiastic and thriving client base. The number of clients that are using ClinSpark is rapidly growing. Our clients are based globally and include both commercial CRO and Large Pharma organizations.
We believe that the strength of our solution is for a large part determined by its interaction with other systems. Therefore, we are also very pleased to have strong connections with leading partners in the industry.